The results showed that, in breast, kidney, liver, lung, prostate, and skin cancers, TOP2A expression was significantly upregulated in the tumor than in the normal control tissues; as well as in the metastatic versus the tumor tissues (Figure 3E). Here, TOP2A is linked to skin cancer.